PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
30701919-13	2018	Hematologic adverse events (AEs) were more frequently observed in patients receiving ce-pegalpha-INF-alpha-2b therapy.	ce-pegalpha	85-96	interferon alpha 17	Homo sapiens	97-106